Diseases associated with complement system dysregulation and the prospects of their treatment
- Authors: Umnyakova ES1, Pashinskaya LD2, Krenev IA2, Legkovoy SV2, Kokryakov VN1,2, Berlov MN1,2
-
Affiliations:
- Institute of Experimental Medicine
- Saint Petersburg State University
- Issue: Vol 18, No 3 (2018)
- Pages: 7-16
- Section: Articles
- URL: https://journals.eco-vector.com/MAJ/article/view/10926
- DOI: https://doi.org/10.17816/MAJ1837-16
- ID: 10926
Cite item
Abstract
Full Text
About the authors
E S Umnyakova
Institute of Experimental Medicine
L D Pashinskaya
Saint Petersburg State University
I A Krenev
Saint Petersburg State University
S V Legkovoy
Saint Petersburg State University
V N Kokryakov
Institute of Experimental Medicine; Saint Petersburg State University
M N Berlov
Institute of Experimental Medicine; Saint Petersburg State University
References
- Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT. Complement System Part I - Molecular Mechanisms of Activation and Regulation. Front Immunol. 2015;6:262. doi: 10.3389/fimmu.2015.00262.
- Erdei A, Sandor N, Macsik-Valent B, et al. The versatile functions of complement C3-derived ligands. Immunol Rev. 2016;274(1):127-140. doi: 10.1111/imr.12498.
- Tomlinson S, Taylor PW, Morgan BP, Luzio JP. Killing of gram-negative bacteria by complement. Fractionation of cell membranes after complement C5b-9 deposition on to the surface of Salmonella Minnesota Re595. Biochem J. 1989;263(2):505-511. doi: 10.1042/bj2630505.
- Bloch EF, Knight EM, Carmon T, et al. C5b-7 and C5b-8 precursors of the membrane attack complex (C5b-9) are effective killers of E. Coli J5 during serum incubation. Immunol Invest. 2009;26(4):409-419. doi: 10.3109/08820139709022698.
- Berends ET, Dekkers JF, Nijland R, et al. Distinct localization of the complement C5b-9 complex on Gram-positive bacteria. Cell Microbiol. 2013;15(12):1955-1968. doi: 10.1111/cmi.12170.
- Hoover DL, Berger M, Nacy CA, et al. Killing of Leishmania tropica amastigotes by factors in normal human serum. J Immunol. 1984;132(2):893-897.
- Koski CL, Ramm LE, Hammer CH, et al. Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics. Proc Natl Acad Sci U S A. 1983;80(12):3816-3820. doi: 10.1073/pnas.80.12.3816.
- Kim SH, Carney DF, Hammer CH, Shin ML. Nucleated cell killing by complement: effects of C5b-9 channel size and extracellular Ca2+ on the lytic process. J Immunol. 1987;138(5):1530-1536.
- Nauta AJ, Daha MR, Tijsma O, et al. The membrane attack complex of complement induces caspase activation and apoptosis. Eur J Immunol. 2002;32(3):783. doi: 10.1002/1521-4141(200203)32:3<783::aid-immu783>3.0.co;2-q.
- Li CKN. Proof of the one-hit mechanism of complement-induced lysis. Immunochemistry. 1975;12(1):89-92. doi: 10.1016/0019-2791(75)90054-3.
- Hein E, Garred P. The Lectin Pathway of Complement and Biocompatibility. Adv Exp Med Biol. 2015;865:77-92. doi: 10.1007/978-3-319-18603-0_5.
- Lintner KE, Wu YL, Yang Y, et al. Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases. Front Immunol. 2016;7:36. doi: 10.3389/fimmu.2016.00036.
- Bohlson SS, O’Conner SD, Hulsebus HJ, et al. Complement, c1q, and c1q-related molecules regulate macrophage polarization. Front Immunol. 2014;5:402. doi: 10.3389/fimmu.2014.00402.
- Kishore U, Gaboriaud C, Waters P, et al. C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol. 2004;25(10):551-561. doi: 10.1016/j.it.2004.08.006.
- Nauta AJ, Bottazzi B, Mantovani A, et al. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur J Immunol. 2003;33(2):465-473. doi: 10.1002/immu.200310022.
- Roumenina LT, Popov KT, Bureeva SV, et al. Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide. Biochim Biophys Acta. 2008;1784(9):1271-1276. doi: 10.1016/j.bbapap.2008.04.029.
- Flierman R, Daha MR. The clearance of apoptotic cells by complement. Immunobiology. 2007;212(4-5):363-370. doi: 10.1016/j.imbio.2006.11.005.
- Trouw LA, Blom AM, Gasque P. Role of complement and complement regulators in the removal of apoptotic cells. Mol Immunol. 2008;45(5):1199-1207. doi: 10.1016/j.molimm.2007.09.008.
- Zipfel PF, Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol. 2009;9(10):729-740. doi: 10.1038/nri2620.
- Merle NS, Noe R, Halbwachs-Mecarelli L, et al. Complement System Part II: Role in Immunity. Front Immunol. 2015;6:257. doi: 10.3389/fimmu.2015.00257.
- Panelius J, Meri S. Complement system in dermatological diseases - fire under the skin. Front Med (Lausanne). 2015;2:3. doi: 10.3389/fmed.2015.00003.
- Tichaczek-Goska D. Deficiencies and excessive human complement system activation in disorders of multifarious etiology. Adv Clin Exp Med. 2012;21(1):105-114.
- Ricklin D, Lambris JD. Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol. 2013;190(8):3831-3838. doi: 10.4049/jimmunol.1203487.
- Liszewski MK, Java A, Schramm EC, Atkinson JP. Complement Dysregulation and Disease: Insights from Contemporary Genetics. Annu Rev Pathol. 2017;12:25-52. doi: 10.1146/annurev-pathol-012615- 044145.
- Leffler J, Bengtsson AA, Blom AM. The complement system in systemic lupus erythematosus: an update. Ann Rheum Dis. 2014;73(9):1601-1606. doi: 10.1136/annrheumdis-2014-205287.
- Yin Y, Wu X, Shan G, Zhang X. Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis. Lupus. 2012;21(10):1088-1097. doi: 10.1177/0961203312451202.
- Edwards AO, Ritter R, 3rd, Abel KJ, et al. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308(5720):421-424. doi: 10.1126/science.1110189.
- Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A. 2005;102(20):7227-7232. doi: 10.1073/pnas.0501536102.
- Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308(5720):419-421. doi: 10.1126/science.1110359.
- Klein RJ. Complement Factor H Polymorphism in Age-Related Macular Degeneration. Science. 2005;308(5720):385-389. doi: 10.1126/science.1109557.
- Shih AR, Murali MR. Laboratory tests for disorders of complement and complement regulatory proteins. Am J Hematol. 2015;90(12):1180-1186. doi: 10.1002/ajh.24209.
- Carugati A. C1-inhibitor deficiency and angioedema. Mol Immunol. 2001;38(2-3):161-173. doi: 10.1016/s0161-5890(01)00040-2.
- Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis - a new look at an old entity. N Engl J Med. 2012;366(12):1119-1131. doi: 10.1056/NEJMra1108178.
- Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med. 2009;361(17):1676-1687. doi: 10.1056/NEJMra0902814.
- Malina M, Roumenina LT, Seeman T, et al. Genetics of hemolytic uremic syndromes. Presse Med. 2012;41(3 Pt 2):e105-114. doi: 10.1016/j.lpm.2011.10.028.
- Marinozzi MC, Vergoz L, Rybkine T, et al. Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign? J Am Soc Nephrol. 2014;25(9):2053-2065. doi: 10.1681/ASN.2013070796.
- Dragon-Durey MA, Sethi SK, Bagga A, et al. Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome. J Am Soc Nephrol. 2010;21(12):2180-2187. doi: 10.1681/ASN.2010030315.
- Bresin E, Rurali E, Caprioli J, et al. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype. J Am Soc Nephrol. 2013;24(3):475-486. doi: 10.1681/ASN.2012090884.
- Fakhouri F, Fremeaux-Bacchi V, Noel LH, et al. C3 glomerulopathy: a new classification. Nat Rev Nephrol. 2010;6(8):494-499. doi: 10.1038/nrneph.2010.85.
- Dragon-Durey MA, Blanc C, Marinozzi MC, et al. Autoantibodies against complement components and functional consequences. Mol Immunol. 2013;56(3):213-221. doi: 10.1016/j.molimm.2013.05.009.
- Servais A, Noel LH, Roumenina LT, et al. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int. 2012;82(4):454-464. doi: 10.1038/ki.2012.63.
- Parker CJ. Management of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitory therapy. Hematology Am Soc Hematol Educ Program. 2011;2011:21-29. doi: 10.1182/asheducation-2011.1.21.
- Berentsen S. Role of Complement in Autoimmune Hemolytic Anemia. Transfus Med Hemother. 2015;42(5):303-310. doi: 10.1159/000438964.
- Alexander JJ, Anderson AJ, Barnum SR, et al. The complement cascade: Yin-Yang in neuroinflammation - neuro-protection and -degeneration. J Neurochem. 2008;107(5):1169-1187. doi: 10.1111/j.1471-4159.2008.05668.x.
- Guo RF, Ward PA. Role of C5a in inflammatory responses. Annu Rev Immunol. 2005;23:821-852. doi: 10.1146/annurev.immunol.23.021704.115835.
- Markiewski MM, DeAngelis RA, Lambris JD. Complexity of complement activation in sepsis. J Cell Mol Med. 2008;12(6A):2245-2254. doi: 10.1111/j.1582-4934.2008.00504.x.
- Diepenhorst GM, van Gulik TM, Hack CE. Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies. Ann Surg. 2009;249(6):889-899. doi: 10.1097/SLA.0b013e3181a38f45.
- Кокряков В.Н., Алешина Г.М., Берлов М.Н., и др. Антимикробные пептиды животных как молекулярные факторы иммунитета // Российский иммунологический журнал. - 2014. - T. 8. - № 3. - С. 325-328. [Kokryakov VN, Aleshina GM, Berlov MN, et al. Animal antimicrobial peptides as molecular factors of the immunity. Russ J Immunol. 2014;8(3):325-328. (In Russ.)]
- Otvos L, Jr. Immunomodulatory effects of anti-microbial peptides. Acta Microbiol Immunol Hung. 2016;63(3):257-277. doi: 10.1556/030.63.2016.005.
- Proha´szka Zn, Ne´met K, Csermely Pt, et al. Defensins purified from human granulocytes bind C1q and activate the classical complement pathway like the transmenbrane glycoprotein gq41 of HIV-1. Mol Immunol. 1997;34(11):809-816. doi: 10.1016/s0161-5890(97)00097-7.
- Bhat S, Song YH, Lawyer C, Milner SM. Modulation of the complement system by human beta-defensin 2. J Burns Wounds. 2007;5:e10.
- Groeneveld TW, Ramwadhdoebe TH, Trouw LA, et al. Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation. Mol Immunol. 2007;44(14):3608-3614. doi: 10.1016/j.molimm.2007.03.003.
- van den Berg RH, Faber-Krol MC, van Wetering S, et al. Inhibition of activation of the classical pathway of complement by human neutrophil defensins. Blood. 1998;92(10):3898-3903.
- Chen J, Xu XM, Underhill CB, et al. Tachyplesin activates the classic complement pathway to kill tumor cells. Cancer Res. 2005;65(11):4614-4622. doi: 10.1158/0008-5472.CAN-04-2253.
- Умнякова Е.С., Леонова Т.С., Берлов М.Н., Кокряков В.Н. Взаимодействие антимикробных пептидов с белком комплемента C1q // Медицинский академический журнал. - 2016. - Т. 16. - № 4. - С. 241-242. [Umnyakova ES, Leonova TS, Berlov MN, Kokryakov VN. Vzaimodeystvie antimikrobnykh peptidov s belkom komplementa C1q. Medical academic journal. 2016;16(4):241-242. (In Russ.)]
- Умнякова Е.С., Берлов М.Н., Кокряков В.Н. Дефенсины как регуляторы системы комплемента // Российский иммунологический журнал. - 2014. - T. 8. - № 3. - С. 414-417. [Umnyakova ES, Berlov MN, Kokryakov VN. Defensins as regulators of the complement system. Russ J Immunol. 2014;8(3):414-417. (In Russ.)]
- Берлов М.Н., Умнякова Е.С., Леонова Т.С., и др. Взаимодействие ареницина-1 с белком С1q // Биоорганическая химия. - 2015. - Т. 41. - № 6. - С. 664-668. [Berlov MN, Umnyakova ES, Leonova TS, et al. Interaction of arenicin-1 with C1q protein. Bioorg Khim. 2015;41(6):664-648. (In Russ.)]. doi: 10.7868/S0132342315060032.
- Берлов М.Н., Умнякова Е.С., Леонова Т.С., и др. Действие антимикробных пептидов на активацию системы комплемента // Российский иммунологический журнал. - 2016. - Т. 10. - № 2-1. - С. 75-77. [Berlov MN, Umnyakova ES, Leonova TS, et al. Deystvie antimikrobnykh peptidov na aktivatsiyu sistemy komplementa. Russ J Immunol. 2016;10(2-1):75-77. (In Russ.)]
- Sahu A. Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3. Mol Immunol. 2003;39(10):557-566. doi: 10.1016/s0161-5890(02)00212-2.
- Soulika AM, Holland MC, Sfyroera G, et al. Compstatin inhibits complement activation by binding to the beta-chain of complement factor 3. Mol Immunol. 2006;43(12):2023-2029. doi: 10.1016/j.molimm.2005.12.002.